These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 362026)

  • 21. Modulation of the humoral response in Pseudomonas aeruginosa-infected mice.
    Izdebska-Szymona K; Sitnicka E; Nowakowska K; Drela N
    Arch Immunol Ther Exp (Warsz); 1984; 32(6):689-94. PubMed ID: 6536239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spleen cell transfer induces T cell-dependent granulomas in tuberculous nude mice.
    Ueda K; Yamazaki S; Yamamoto S; Someya S
    J Reticuloendothel Soc; 1982 Jun; 31(6):469-78. PubMed ID: 6750116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation.
    Murphy JR
    Infect Immun; 1981 Jul; 33(1):199-211. PubMed ID: 7021424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCG-induced susceptibility of mice to challenge with Pseudomonas aeruginosa.
    Lal S; Mitsuyama M; Ogata N; Miyata M; Miake S; Nomoto K
    J Gen Microbiol; 1983 Jan; 129(1):93-8. PubMed ID: 6403661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of the histologic reactions to intravenous injections of heat-killed Pseudomonas aeruginosa and of BCG.
    Khalil A; Rappaport H; Florentin I; Bennoun M; Davigny M; Mathé G
    Biomedicine; 1979 Oct; 30(4):200-5. PubMed ID: 119556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross immunity between mycobacterial and Pseudomonas pseudomallei infections in mice.
    Hobby GL; Lenert TF
    Am Rev Respir Dis; 1971 Apr; 103(4):569-71. PubMed ID: 4927632
    [No Abstract]   [Full Text] [Related]  

  • 28. Passive immunisation against Gram-negative bacilli in burns.
    Jones RJ
    Br J Exp Pathol; 1970 Feb; 51(1):53-8. PubMed ID: 4985031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced resistance to Pseudomonas septicaemia in diabetic mice.
    Kitahara Y; Ishibashi T; Harada Y; Takamoto M; Tanaka K
    Clin Exp Immunol; 1981 Mar; 43(3):590-8. PubMed ID: 7026096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Micrococcus, BCG and related polysaccharides in the specific and non-specific immune resistance to murine L1210 leukemia [proceedings].
    Verloes R; Atassi G; Dumont P; Kanarek L
    Arch Int Physiol Biochim; 1978 May; 86(2):466-8. PubMed ID: 81034
    [No Abstract]   [Full Text] [Related]  

  • 31. Vertical transmission of tumour resistance in guinea pigs.
    Wainberg MA; Minden P; Weiss DW
    Nature; 1976 Jan; 259(5540):213-5. PubMed ID: 175279
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of Mycobacterium tuberculosis BCG infection on the resistance of mice to ectromelia virus infection: participation of interferon in enhanced resistance.
    Suenaga T; Okuyama T; Yoshida I; Azuma M
    Infect Immun; 1978 Apr; 20(1):312-4. PubMed ID: 208973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunological changes of splenic cells in BCG infected mice].
    Saito T; Aso M; Tanabe M; Nakano M
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):212. PubMed ID: 765554
    [No Abstract]   [Full Text] [Related]  

  • 34. Passive immunity against pseudomonas sepsis during granulocytopenia.
    Harvath L; Andersen BR; Amirault HJ
    Infect Immun; 1976 Nov; 14(5):1151-5. PubMed ID: 824205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Etiology of sepsis occurring in the immunocompromised host and its prevention. 2. Preventive effect of BRM to experimental Pseudomonas endogenous septicemia and analysis of its immunological etiology].
    Tomono K
    Kansenshogaku Zasshi; 1989 Jun; 63(6):557-64. PubMed ID: 2614093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of lymphocytotherapy on the course of experimental Pseudomonas sepsis.
    Munster AM; Leary AG; Spicer SS; Fisher MW
    Ann Surg; 1974 Apr; 179(4):482-8. PubMed ID: 4593102
    [No Abstract]   [Full Text] [Related]  

  • 37. [BCG-septicemia and mucocutaneous candidiasis due to familial combined immunodeficiency (authors transl)].
    Lachmann D; Jarisch R; Eibl M; Male O; Radaszkeiwicz T
    Monatsschr Kinderheilkd (1902); 1976 Jan; 124(1):32-5. PubMed ID: 1107821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance of female mice to vaginal infection induced by Herpesvirus hominis type 2: effects of immunization with Mycobacterium bovis, intravenous injection of specific Herpesvirus hominis type 2 antiserum, and a combination of these procedures.
    Baker MB; Larson CL; Ushijima RN; Anderson FD
    Infect Immun; 1974 Dec; 10(6):1230-4. PubMed ID: 4373394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. USE OF VACCINE AND HYPERIMMUNE SERUM FOR PROTECTION AGAINST PSEUDOMONAS SEPTICEMIA.
    FELLER I; VIAL AB; CALLAHAN W; WALDYKE J
    J Trauma; 1964 Jul; 4():451-6. PubMed ID: 14178838
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor-necrotizing serum production by administration of BCG + Pseudomonas: its application in treatment of fibrosarcoma in mice.
    Kiger N; Khalil A; Mathé G
    Recent Results Cancer Res; 1980; 75():220-5. PubMed ID: 7015426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.